On March 11, 2023 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, reported that Dr. Amit Kumar, Chairman and CEO of Anixa, will participate in the 24th Annual World Vaccine Congress being held April 1-4, 2024 (Press release, Anixa Biosciences, MAR 11, 2024, View Source [SID1234641001]). Dr. Kumar will speak on Thursday, April 4th, in the Cancer Immunotherapy Track.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details are as follows:

Location:

Walter E. Washington Convention Center, Washington, D.C.

Tickets:

Visit the conference website.

Session:

April 4, 2024 | Cancer Immunotherapy

Emerging Targets & Strategies track

11:45 a.m.: "Early-stage clinical results from a novel preventative breast cancer vaccine."

Dr. Kumar will speak about positive interim results from the Phase 1 clinical trial of Anixa’s breast cancer vaccine. In the most recent data, 75% of women showed immune responses, with responses observed at all dose levels. The vaccine is designed to direct the immune system to destroy triple negative breast cancer (TNBC) cancer cells through a mechanism that has never previously been utilized for cancer vaccine development. The trial is being conducted in collaboration with Cleveland Clinic with funding by a grant from the U.S. Department of Defense.

Dr. Kumar will be available during the Congress for one-on-one meetings.

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe since 2000. The World Vaccine Congress Washington 2024 will host 4,000+ attendees, 450+ speakers, and 350+ exhibitors.